Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review
Abstract
Rationale Patients with schizophrenia exhibit deficits in an operational measure of sensorimotor gating: prepulse inhibition (PPI) of startle. Similar deficits in PPI are produced in rats by pharmacological or developmental manipulations. These experimentally induced PPI deficits in rats are clearly not animal models of schizophrenia per se, but appear to provide models of sensorimotor gating deficits in schizophrenia patients that have face, predictive, and construct validity. In rodents, disruptions in PPI of startle are produced by: stimulation of D2 dopamine (DA) receptors, produced by amphetamine or apomorphine; activation of serotonergic systems, produced by serotonin (5-HT) releasers or direct agonists at multiple serotonin receptors; and blockade of N-methyl-D-aspartate (NMDA) receptors, produced by drugs such as phencyclidine (PCP). Accordingly, dopaminergic, serotonergic, and glutamatergic models of disrupted PPI have evolved and have been applied to the identification of potential antipsychotic treatments. In addition, some developmental manipulations, such as isolation rearing, have provided non-pharmacological animal models of the PPI deficits seen in schizophrenia.Objective This review summarizes and evaluates studies assessing the effects of systemic drug administrations on PPI in rats.Methods Studies examining systemic drug effects on PPI in rats prior to January 15, 2001 were compiled and organized into six annotated appendices. Based on this catalog of studies, the specific advantages and disadvantages of each of the four main PPI models used in the study of antipsychotic drugs were critically evaluated.Results Despite some notable inconsistencies, the literature provides strong support for significant disruptions in PPI in rats produced by DA agonists, 5-HT2 agonists, NMDA antagonists, and isolation rearing. Each of these models exhibits sensitivity to at least some antipsychotic medications. While the PPI model based on the effects of direct DA agonists is the most well-validated for the identification of known antipsychotics, the isolation rearing model also appears to be sensitive to both typical and atypical antipsychotics. The 5-HT PPI model is less generally sensitive to antipsychotic medications, but can provide insight into the contribution of serotonergic systems to the actions of newer antipsychotics that act upon multiple receptors. The deficits in PPI produced by NMDA antagonists appear to be more sensitive to clozapine-like atypical antipsychotics than to typical antipsychotics. Hence, despite some exceptions to this generalization, the NMDA PPI model might aid in the identification of novel or atypical antipsychotic medications.Conclusions Studies of drug effects on PPI in rats have generated four distinctive models that have utility in the identification of antipsychotic medications. Because each of these models has specific advantages and disadvantages, the choice of model to be used depends upon the question being addressed. This review should help to guide such decisions.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Both apomorphine-induced and amphetamine-induced PPI disruptions in rats are blocked by DA D2 antagonists.
“both apomorphine-induced and amphetamine-induced PPI disruptions in rats are blocked by DA D2 antagonists [366].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [366]
A weak tone initiates habituation of the reticular neurons' response to a successive louder tone, leading to prepulse inhibition of the acoustic startle response.
“A weak tone initiates habituation of the reticular neurons’ response to a successive louder tone, leading to the phenomenon of prepulse inhibition (PPI) of the acoustic startle response (7, 8).”
From Sensory Processing Dysfunction in the Personal Experience and Neuronal Machinery of Schizophrenia (2015) · cites this paper as [8]
For both PPI and P50 gating, despite the origin of the effect in reticular brain stem neurons, the response engages an entire network of brain circuits, the dopaminergic circuits of the basal ganglia for PPI and the basal cholinergic nuclei and cortex for P50 gating.
“For both PPI and P50 gating, despite the origin of the effect in reticular brain stem neurons, the response engages an entire network of brain circuits, the dopaminergic circuits of the basal ganglia for PPI and the basal cholinergic nuclei and cortex for P50 gating (8, 9).”
From Sensory Processing Dysfunction in the Personal Experience and Neuronal Machinery of Schizophrenia (2015) · cites this paper as [8]
Deficits in CHRNA7 null mutant mice for P50 gating and in NRG-1 null mutants for PPI have been reported.
“Deficits in CHRNA7 null mutant mice for P50 gating (32) and in NRG-1 null mutants for PPI have also been reported (8).”
From Sensory Processing Dysfunction in the Personal Experience and Neuronal Machinery of Schizophrenia (2015) · cites this paper as [8]
Increased dopaminergic neurotransmission from stimulants and psychotomimetic antagonists of NMDARs such as phencyclidine induce the PPI/P50 deficit pharmacologically.
“Increased dopaminergic neurotransmission from stimulants and psychotomimetic antagonists of NMDARs such as phencyclidine (PCP) induce the deficit pharmacologically (8).”
From Sensory Processing Dysfunction in the Personal Experience and Neuronal Machinery of Schizophrenia (2015) · cites this paper as [8]
Cites
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904 · see citing works
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476 · see citing works
BRAFF, D. L., Geyer, M. A., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100810 · Cited by 1,701 · see citing works
Self-citationSensorimotor Gating and Schizophrenia
Braff, D. L. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810140081011 · Cited by 1,312 · see citing works
Self-citationDisorders of attention and perception in early schizophrenia
McGhie, A., & Chapman, J. (1961) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1961.tb00936.x · Cited by 1,195 · see citing works
Prestimulus Effects on Human Startle Reflex in Normals and Schizophrenics
BRAFF, D. L., Stone, C., Callaway, E., Geyer, M. A., Glick, I. D., & Bali, L. (1978) · Psychophysiology · doi:10.1111/j.1469-8986.1978.tb01390.x · Cited by 1,171 · see citing works
Self-citationSwerdlow, N. R., Geyer, M. A., & BRAFF, D. L. (2001) · Psychopharmacology · doi:10.1007/s002130100799 · Cited by 1,053 · see citing works
Self-citationGating and Habituation of the Startle Reflex in Schizophrenic Patients
Braff, D. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820030038005 · Cited by 1,027 · see citing works
Self-citationSubanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia
Lahti, A. C., Koffel, B., LaPorte, D. J., & Tamminga, C. A. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(94)00131-i · Cited by 921 · see citing works
Study of a New Schizophrenomimetic Drug—Sernyl
LUBY, E. D. (1959) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1959.02340150095011 · Cited by 921 · see citing works
Current Protocols in Neuroscience
(2018) · Current Protocols in Neuroscience · doi:10.1002/(issn)1934-8576 · Cited by 771 · see citing works
Assessing the Validity of an Animal Model of Deficient Sensorimotor Gating in Schizophrenic Patients
Swerdlow, N. R. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020063007 · Cited by 708 · see citing works
Self-citationDopaminergic stimulation disrupts sensorimotor gating in the rat
Mansbach, R. S., Geyer, M. A., & BRAFF, D. L. (1988) · Psychopharmacology · doi:10.1007/bf00212846 · Cited by 608 · see citing works
Self-citationStartle response models of sensorimotor gating and habituation deficits in schizophrenia
Geyer, M. A., Swerdlow, N. R., Mansbach, R. S., & Braff, D. L. (1990) · Brain Research Bulletin · doi:10.1016/0361-9230(90)90241-q · Cited by 456 · see citing works
Self-citationSwerdlow, N. R., Paulsen, J. S., BRAFF, D. L., Butters, N., Geyer, M. A., & Swenson, M. R. (1995) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.58.2.192 · Cited by 436 · see citing works
Self-citationSensorimotor gating in boys with Tourette's syndrome and ADHD: Preliminary results
Castellanos, F. X., Fine, E. J., Kaysen, D. L., Marsh, W., Rapoport, J. L., & Hallett, M. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00101-8 · Cited by 395 · see citing works
Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat*1
Mansbach, R. S. (1989) · Neuropsychopharmacology · doi:10.1016/0893-133x(89)90035-3 · Cited by 380 · see citing works
Geyer, M. A., Wilkinson, L. S., Humby, T., & Robbins, T. W. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90180-l · Cited by 377 · see citing works
Self-citationA preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder
Swerdlow, N. R., Benbow, C. H., Zisook, S., Geyer, M. A., & BRAFF, D. L. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90300-3 · Cited by 351 · see citing works
Self-citationCentral dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics
Swerdlow, N. R., BRAFF, D. L., Geyer, M. A., & Koob, G. F. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90005-3 · Cited by 341 · see citing works
Self-citationClozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response.
Bakshi, V. P., Swerdlow, N. R., & Geyer, M. A. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23831-9 · Cited by 330 · see citing works
Self-citationReavill, C., Taylor, S. G., Wood, M. D., Ashmeade, T., Austin, N. E., Avenell, K. Y., Boyfield, I., Branch, C. L., Cilia, J., Coldwell, M. C., et al. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39184-0 · Cited by 287 · see citing works
Ralph, R. J., Paulus, M. P., Fumagalli, F., Caron, M. G., & Geyer, M. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-01-00305.2001 · Cited by 271 · see citing works
Self-citationMODEL PSYCHOSES AND SCHIZOPHRENIA
Luby, E. D., Gottlieb, J. S., Cohen, B. D., Rosenbaum, G., & Domino, E. F. (1962) · American Journal of Psychiatry · doi:10.1176/ajp.119.1.61 · Cited by 268 · see citing works
Wilkinson, L. S., Killcross, S., Humby, T., Hall, F. S., Geyer, M. A., & Robbins, T. W. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.8 · Cited by 267 · see citing works
Self-citationThe effects of an early stressful life event on sensorimotor gating in adult rats
Ellenbroek, B. A., van den Kroonenberg, P. T. J. M., & Cools, A. R. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00149-7 · Cited by 265 · see citing works
Swerdlow, N. R., Keith, V. A., BRAFF, D. L., & Geyer, M. A. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23018-x · Cited by 247 · see citing works
Self-citationVarty, G. B., Higgins, G. A., & Higgins, G. A. (1995) · Psychopharmacology · doi:10.1007/bf02246437 · Cited by 231 · see citing works
Lehmann, J., Stöhr, T., & Feldon, J. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00122-9 · Cited by 220 · see citing works
Measurement of Startle Response, Prepulse Inhibition, and Habituation
Geyer, M. A., & Swerdlow, N. R. (1998) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0807s03 · Cited by 219 · see citing works
Self-citationVarty, G. B., Paulus, M. P., BRAFF, D. L., & Geyer, M. A. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00269-3 · Cited by 211 · see citing works
Self-citationClozapine Blunts N-Methyl-d-Aspartate Antagonist-Induced Psychosis: A Study with Ketamine
Malhotra, A. K., Adler, C. M., Kennison, S. D., Elman, I., Pickar, D., & Breier, A. F. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00546-x · Cited by 200 · see citing works
Sallinen, J., Haapalinna, A., Viitamaa, T., Kobilka, B. K., & Scheinin, M. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-08-03035.1998 · Cited by 196 · see citing works
Environmental animal models for sensorimotor gating deficiencies in schizophrenia: a review
Weiss, I. C., & Feldon, J. (2001) · Psychopharmacology · doi:10.1007/s002130100800 · Cited by 194 · see citing works
Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia
Swerdlow, N. R., & Geyer, M. A. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90193-w · Cited by 191 · see citing works
Self-citationMultiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats
Sipes, T. E., & Geyer, M. A. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90074-4 · Cited by 184 · see citing works
Self-citationRalph, R. J., Varty, G. B., Kelly, M. A., Wang, Y.-M., Caron, M. G., Rubinstein, M., Grandy, D. K., Low, M. J., & Geyer, M. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04627.1999 · Cited by 174 · see citing works
Self-citationCycling cells in the adult rat neocortex preferentially generate oligodendroglia
Levison, S. W., Young, G. M., & Goldman, J. E. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990815)57:4 · Cited by 172 · see citing works
Bakshi, V. P., & Geyer, M. A. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08394.1998 · Cited by 167 · see citing works
Self-citationSwerdlow, N. R., Martinez, Z. A., Hanlon, F. M., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04325.2000 · Cited by 163 · see citing works
Self-citationEffects of apomorphine and amphetamine on patterns of locomotor and investigatory behavior in rats
Geyer, M. A., Russo, P. V., Segal, D. S., & Kuczenski, R. T. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90460-6 · Cited by 161 · see citing works
Self-citationSeroquel restores sensorimotor gating in phencyclidine-treated rats.
Swerdlow, N. R., Bakshi, V. P., & Geyer, M. A. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21289-7 · Cited by 155 · see citing works
Self-citationClinical and Sensorimotor Gating Effects of Ketamine in Normals
Duncan, E. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00240-2 · Cited by 150 · see citing works
Johansson, C., Jackson, D. M., Zhang, J., & Svensson, L. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00160-x · Cited by 148 · see citing works
van Berckel, B. N. M., Oranje, B., van Ree, J. M., Verbaten, M. N., & Kahn, R. S. (1998) · Psychopharmacology · doi:10.1007/s002130050620 · Cited by 148 · see citing works
Sensorimotor gating changes across the estrous cycle in female rats
Koch, M. (1998) · Physiology & Behavior · doi:10.1016/s0031-9384(98)00098-5 · Cited by 145 · see citing works
Role of serotonin in the action of atypical antipsychotic drugs.
Hy, M. (1995) · PubMed · Cited by 145 · see citing works
Parametric determinants in pre-stimulus modification of acoustic startle: interaction with ketamine
Mansbach, R. S., & Geyer, M. A. (1991) · Psychopharmacology · doi:10.1007/bf02244303 · Cited by 140 · see citing works
Self-citationApomorphine disrupts the inhibition of acoustic startle induced by weak prepulses in rats
Davis, M., Mansbach, R. S., Swerdlow, N. R., Campeau, S., Braff, D. L., & Geyer, M. A. (1990) · Psychopharmacology · doi:10.1007/bf02245735 · Cited by 139 · see citing works
Self-citationVarty, G. B., Bakshi, V. P., & Geyer, M. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00072-4 · Cited by 137 · see citing works
Self-citationPeng, R. Y., Mansbach, R. S., BRAFF, D. L., & Geyer, M. A. (1990) · PubMed · Cited by 137 · see citing works
Self-citationReversal of Isolation Rearing-Induced Deficits in Prepulse Inhibition by Seroquel and Olanzapine
Bakshi, V. P., Swerdlow, N. R., Braff, D. L., & Geyer, M. A. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00246-1 · Cited by 135 · see citing works
Self-citationEffects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats
Mansbach, R. S., Rovetti, C. C., Winston, E., & Lowe, J. A., III (1996) · Psychopharmacology · doi:10.1007/bf02247436 · Cited by 134 · see citing works
Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats
Swerdlow, N. R., Bakshi, V. P., Waikar, M. V., Taaid, N., & Geyer, M. A. (1998) · Psychopharmacology · doi:10.1007/s002130050741 · Cited by 131 · see citing works
Self-citationRole of dopamine in prepulse inhibition of acoustic startle
Zhang, J., Forkstam, C., Engel, J., & Svensson, L. (2000) · Psychopharmacology · doi:10.1007/s002130000369 · Cited by 129 · see citing works
5-Hydroxytryptamine 1a receptor agonists block prepulse inhibition of acoustic startle reflex.
Rigdon, G. C., & Weatherspoon, J. K. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10375-3 · Cited by 127 · see citing works
Ouagazzal, A., Jenck, F., & Moreau, J.-L. (2001) · Psychopharmacology · doi:10.1007/s002130100763 · Cited by 124 · see citing works
Dulawa, S. C., Hen, R., Scearce-Levie, K. A., & Geyer, M. A. (1997) · Psychopharmacology · doi:10.1007/s002130050328 · Cited by 122 · see citing works
Self-citationOxytocin modulates psychotomimetic-induced deficits in sensorimotor gating
Feifel, D., & Reza, T. L. (1999) · Psychopharmacology · doi:10.1007/s002130050811 · Cited by 121 · see citing works
DOI disrupts prepulse inhibition of startle in rats via 5-HT2A receptors in the ventral pallidum
Sipes, T. E., & Geyer, M. A. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00316-8 · Cited by 118 · see citing works
Self-citationSipes, T. E., & Geyer, M. A. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199512000-00010 · Cited by 117 · see citing works
Self-citationEffects of Nicotine and Stress on Startle Amplitude and Sensory Gating Depend on Rat Strain and Sex
Faraday, M. M., O’Donoghue, V. A., & Grunberg, N. E. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00159-2 · Cited by 115 · see citing works
Ontogeny of Isolation Rearing-Induced Deficits in Sensorimotor Gating in Rats
Bakshi, V. P., & Geyer, M. A. (1999) · Physiology & Behavior · doi:10.1016/s0031-9384(99)00082-7 · Cited by 113 · see citing works
Self-citationWeiss, I. C., Iorio, L. D., Feldon, J., & Domeney, A. M. (2000) · Behavioral Neuroscience · doi:10.1037/0735-7044.114.2.364 · Cited by 109 · see citing works
Ralph, R. J., Paulus, M. P., & Geyer, M. A. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29362-9 · Cited by 109 · see citing works
Self-citationThe Long-Term Effects of Maternal Deprivation Depend on the Genetic Background
Ellenbroek, B. A. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00088-9 · Cited by 105 · see citing works
Muscarinic Cholinergic Modulation of Prepulse Inhibition of the Acoustic Startle Reflex
Jones, C. K., & Shannon, H. E. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39166-9 · Cited by 104 · see citing works
Sipes, T. E., & Geyer, M. A. (1995) · Psychopharmacology · doi:10.1007/bf02245096 · Cited by 103 · see citing works
Self-citationBristow, L. J., Collinson, N., Cook, G. P., Curtis, N. R., Freedman, S. B., Kulagowski, J. J., Leeson, P. D., Patel, S., RAGAN, C. I., Ridgill, M. P., et al. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37123-x · Cited by 103 · see citing works
Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats
Cilia, J., Reavill, C. A., Hagan, J. J., & Jones, D. N. C. (2001) · Psychopharmacology · doi:10.1007/s002130100786 · Cited by 102 · see citing works
Liechti, M. E. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00199-8 · Cited by 102 · see citing works
Varty, G. B., & Geyer, M. A. (1998) · Behavioral Neuroscience · doi:10.1037//0735-7044.112.6.1450 · Cited by 100 · see citing works
Self-citationResponding to acoustic startle during chronic ethanol intoxication and withdrawal
Rassnick, S., Koob, G. F., & Geyer, M. A. (1992) · Psychopharmacology · doi:10.1007/bf02245417 · Cited by 100 · see citing works
Self-citationHoffman, D. C., Donovan, H., & Cassella, J. V. (1993) · Psychopharmacology · doi:10.1007/bf02244950 · Cited by 98 · see citing works
Vollenweider, F. X., Remensberger, S., Hell, D., & Geyer, M. A. (1999) · Psychopharmacology · doi:10.1007/s002130050960 · Cited by 97 · see citing works
Self-citationde Bruin, N. M. W. J., Ellenbroek, B. A., Cools, A. R., Coenen, A. M. L., & van Luijtelaar, E. L. J. M. (1999) · Psychopharmacology · doi:10.1007/s002130050856 · Cited by 96 · see citing works
Strain and age differences in acoustic startle responses and effects of nicotine in rats
Acri, J. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)00285-q · Cited by 95 · see citing works
Effect of d -amphetamine on prepulse inhibition of the startle reflex in humans
Hutchison, K. E., & Swift, R. M. (1999) · Psychopharmacology · doi:10.1007/s002130050964 · Cited by 95 · see citing works
Domeney, A. M., & Feldon, J. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00534-0 · Cited by 92 · see citing works
THE EFFECT OF AUDITORY AND VISUAL STIMULATION ON THE SKIN POTENTIAL RESPONSE OF SCHIZOPHRENICS
Venables, P. H. (1960) · Brain · doi:10.1093/brain/83.1.77 · Cited by 92 · see citing works
Psychopharmacology of prepulse inhibition in mice.
Dulawa, S. C., & Geyer, M. A. (1996) · PubMed · Cited by 91 · see citing works
Self-citationSwerdlow, N. R. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00110-3 · Cited by 87 · see citing works
Self-citationNovel Antipsychotic-Like Effects on Prepulse Inhibition of Startle Produced by a Neurotensin Agonist
Feifel, D., Reza, T. L., Wustrow, D. J., & Davis, M. D. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38010-3 · Cited by 84 · see citing works
Prepulse inhibition as a screening test for potential antipsychotics
Rigdon, G. C., & Viik, K. (1991) · Drug Development Research · doi:10.1002/ddr.430230110 · Cited by 84 · see citing works
Kinney, G. G., Wilkinson, L. O., Saywell, K. L., et al. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-13-05644.1999 · Cited by 82 · see citing works
Mansbach, R. S., Brooks, E., Zorn, S. H., & Sanner, M. A. (1998) · Psychopharmacology · doi:10.1007/s002130050501 · Cited by 82 · see citing works
Knockout Mice Reveal Opposite Roles for Serotonin 1A and 1B Receptors in Prepulse Inhibition
Dulawa, S. C. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00164-5 · Cited by 80 · see citing works
Gouzoulis‐Mayfrank, E., Heekeren, K., Thelen, B., Lindenblatt, H., Kovar, K. ‐., Sass, H., & Geyer, M. A. (1998) · Behavioural Pharmacology · doi:10.1097/00008877-199811000-00011 · Cited by 80 · see citing works
Self-citationDo ? Interactions Regulate Prepulse Inhibition in Rats?
Fang-Jung, W. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00133-x · Cited by 79 · see citing works
Johansson, C., Jackson, D. M., & Svensson, L. (1994) · Psychopharmacology · doi:10.1007/bf02247475 · Cited by 79 · see citing works
Johansson, C., Jackson, D. M., & Svensson, L. (1997) · Psychopharmacology · doi:10.1007/s002130050280 · Cited by 79 · see citing works
Effects of MK801 and neuroleptics on prepulse inhibition: re-examination in two strains of rats
Bast, T., Zhang, W., Feldon, J., & White, I. M. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00409-3 · Cited by 78 · see citing works
Effect of nicotine, lobeline, and mecamylamine on sensory gating in the rat
Curzon, P., Kim, D. J. B., & Decker, M. W. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90237-2 · Cited by 76 · see citing works
Al-Amin, H. A., & Schwarzkopf, S. B. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00485-8 · Cited by 76 · see citing works
Kehne, J. H., Padich, R. A., McCloskey, T. C., Taylor, V. L., & Schmidt, C. J. (1996) · Psychopharmacology · doi:10.1007/bf02245609 · Cited by 73 · see citing works
Effects of Sustained Phencyclidine Exposure on Sensorimotor Gating of Startle in Rats
Martinez, Z. A. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00137-7 · Cited by 73 · see citing works
Binder, E. B., Kinkead, B. L., Owens, M. J., Kilts, C. D., & Nemeroff, C. B. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00601.2001 · Cited by 73 · see citing works
Meltzer, H. Y. (1999) · PubMed · Cited by 72 · see citing works
Depoortère, R., Perrault, G., & Sanger, D. J. (1997) · Psychopharmacology · doi:10.1007/s002130050357 · Cited by 72 · see citing works
Caine, S. B., Geyer, M. A., & Swerdlow, N. R. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(94)00071-7 · Cited by 71 · see citing works
Self-citationTalamini, L. M., Koch, T., Horst, G. J. T., & Korf, J. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00020-1 · Cited by 71 · see citing works
Hoffman, D. C., & Donovan, H. (1994) · Psychopharmacology · doi:10.1007/bf02245567 · Cited by 71 · see citing works
Effects of NMDA receptor ligands on sensorimotor gating in the rat
Mansbach, R. S. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90253-m · Cited by 70 · see citing works
Isolation rearing-induced disruption of prepulse inhibition
Weiss, I. C., Feldon, J., & Domeney, A. M. (1999) · Behavioural Pharmacology · doi:10.1097/00008877-199903000-00003 · Cited by 69 · see citing works
Acri, J. B. (1994) · Psychopharmacology · doi:10.1007/bf02245326 · Cited by 69 · see citing works
Disruption in prepulse inhibition after alpha-1 adrenoceptor stimulation in rats
Carasso, B. S., Bakshi, V. P., & Geyer, M. A. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00051-3 · Cited by 68 · see citing works
Self-citationYamada, S., Harano, M., Annoh, N., Nakamura, K., & Tanaka, M. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00356-4 · Cited by 67 · see citing works
Mansbach, R. S., Braff, D. L., & Geyer, M. A. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90746-2 · Cited by 65 · see citing works
Self-citationDavis, M. J. (1988) · Psychopharmacology · doi:10.1007/bf00174500 · Cited by 64 · see citing works
Effects of Prenatal Exposure to Toluene on Postnatal Development and Behavior in Rats
Hougaard, K. S., Hass, U., Lund, S. P., & Simonsen, L. (1999) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(98)00053-1 · Cited by 64 · see citing works
Swerdlow, N. R., Zisook, D. S., & Taaid, N. (1994) · Psychopharmacology · doi:10.1007/bf02245001 · Cited by 62 · see citing works
Self-citationBuspirone: A potential atypical neuroleptic
Wood, P. L., Nair, N. P. V., & Etienne, P. E. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90386-7 · Cited by 61 · see citing works
Jones, C. K., & Shannon, H. E. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00055-8 · Cited by 60 · see citing works
Kodsi, M. H., & Swerdlow, N. R. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00482-5 · Cited by 60 · see citing works
Self-citationBakshi, V. P., Tricklebank, M. D., Neijt, H. C., et al. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38001-2 · Cited by 59 · see citing works
Bakshi, V. P., Geyer, M. A., Taaid, N., & Swerdlow, N. R. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199512000-00005 · Cited by 59 · see citing works
Self-citationEffects of phencyclidne (PCP) and (+)MK-801 on sensorimotor gating in CD-1 mice
Curzon, P., & Decker, M. W. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(97)00184-x · Cited by 58 · see citing works
Campeau, S., & Davis, M. (1995) · Psychopharmacology · doi:10.1007/bf02246101 · Cited by 58 · see citing works
Martinez, D. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00240-0 · Cited by 57 · see citing works
Varty, G. B., & Higgins, G. A. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00660-5 · Cited by 56 · see citing works
Swerdlow, N. R., Taaid, N., Oostwegel, J. L., et al. (1998) · Behavioural Pharmacology · doi:10.1097/00008877-199809000-00002 · Cited by 56 · see citing works
Self-citationLack of effect of an early stressful life event on sensorimotor gating in adult rats
Lehmann, J., Pryce, C. R., & Feldon, J. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00080-8 · Cited by 56 · see citing works
Bristow, L. J., Cook, G. P., Gay, J. C., Kulagowski, J. J., Landon, L. A., Murray, F., Saywell, K. L., Young, L., & Hutson, P. H. (1996) · Neuropharmacology · doi:10.1016/0028-3908(96)00179-7 · Cited by 55 · see citing works
Bristow, L. J., Landon, L. A., Saywell, K. L., et al. (1995) · Psychopharmacology · doi:10.1007/bf02245847 · Cited by 55 · see citing works
Krebs-Thomson, K., Giracello, D. R., Solis, A., & Geyer, M. A. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00374-0 · Cited by 54 · see citing works
Self-citationRecent basic findings in support of excitatory amino acid hypotheses of schizophrenia
Moghaddam, B. (1994) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)90102-3 · Cited by 51 · see citing works
LEHMANNMASTEN, V., & Geyer, M. A. (1991) · Neuropharmacology · doi:10.1016/0028-3908(91)90083-n · Cited by 50 · see citing works
Self-citationNitric Oxide Synthase Inhibitors Attenuate Phencyclidine-Induced Disruption of Prepulse Inhibition
Wiley, J. L. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00008-6 · Cited by 50 · see citing works
Varty, G. B., & Higgins, G. A. (1998) · Behavioural Pharmacology · doi:10.1097/00008877-199809000-00008 · Cited by 50 · see citing works
Long-term effects of prenatal phenytoin exposure on offspring behavior in rats
Vorhees, C. V., & Minck, D. R. (1989) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(89)90072-x · Cited by 50 · see citing works
Wędzony, K., Gołembiowska, K., & Zazula, M. (1994) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00173026 · Cited by 49 · see citing works
Schreiber, R., Lowe, D., Voerste, A. A. W., & Vry, J. D. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00844-4 · Cited by 48 · see citing works
Schwarzkopf, S. B., Bruno, J. P., & Mitra, T. (1993) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(93)90028-q · Cited by 47 · see citing works
The role of 5HT1A receptors in the modulation of the acoustic startle reflex in rats
Nanry, K. P., & Tilson, H. A. (1989) · Psychopharmacology · doi:10.1007/bf00439556 · Cited by 47 · see citing works
PCP (Phencyclidine): An Update
Garey, R. E. (1979) · Journal of Psychedelic Drugs · doi:10.1080/02791072.1979.10471408 · Cited by 47 · see citing works
Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist
Baron, B. M., Harrison, B. L., Kehne, J. H., et al. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00045-9 · Cited by 47 · see citing works
Martin, P., Waters, N., Carlsson, A., & Carlsson, M. L. (1997) · Journal of Neural Transmission · doi:10.1007/bf01277672 · Cited by 43 · see citing works
Wu, M., Jenden, D. J., Fairchild, M. D., & Siegel, J. M. (1993) · Behavioral Neuroscience · doi:10.1037//0735-7044.107.2.306 · Cited by 42 · see citing works
Localizing Haloperidol Effects on Sensorimotor Gating in a Predictive Model of Antipsychotic Potency
Hart, S. A., Zreik, M., Carper, R. A., & Swerdlow, N. R. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00079-3 · Cited by 42 · see citing works
Self-citationNicotine Administration Impairs Sensory Gating in Long–Evans Rats
Faraday, M. M. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00094-x · Cited by 42 · see citing works
Martinez, Z. A. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00147-0 · Cited by 41 · see citing works
Sills, T. L. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00036-2 · Cited by 41 · see citing works
Prenatal exposure to nicotine: effects on prepulse inhibition and central nicotinic receptors.
Popke, E., Tizabi, Y., Rahman, M. A., Nespor, S., & Grunberg, N. (1997) · Pharmacology, Biochemistry and Behavior · doi:10.1016/s0091-3057(97)98985-1 · Cited by 41 · see citing works
Rigdon, G. (2005) · Psychopharmacology · doi:10.1007/bf02244115 · Cited by 41 · see citing works
Ontogeny of Phencyclidine and Apomorphine-Induced Startle Gating Deficits in Rats
Martinez, Z. A., Halim, N. D., Oostwegel, J. L., Geyer, M. A., & Swerdlow, N. R. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00217-8 · Cited by 40 · see citing works
Self-citationEllenbroek, B. A., van Luijtelaar, G., Frenken, M. W. E., & Cools, A. R. (1999) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033418 · Cited by 39 · see citing works
Prepulse inhibition of the startle reflex in rats
Depoortère, R., Perrault, G., & Sanger, D. J. (1999) · Behavioural Pharmacology · doi:10.1097/00008877-199902000-00005 · Cited by 38 · see citing works
Zhang, J., Engel, J. A., Söderpalm, B., et al. (1998) · Psychopharmacology · doi:10.1007/s002130050528 · Cited by 38 · see citing works
Snyder, S. H. (1988) · Neuropsychopharmacology · doi:10.1016/0893-133x(88)90016-4 · Cited by 38 · see citing works
Effects of phencyclidine on prepulse inhibition of acoustic startle response in the macaque
Javitt, D. C., & Lindsley, R. W. (2001) · Psychopharmacology · doi:10.1007/s002130100758 · Cited by 37 · see citing works
Developmental stress disrupts habituation but spares prepulse inhibition in young rats
Finamore, T. L., & Port, R. L. (2000) · Physiology & Behavior · doi:10.1016/s0031-9384(00)00205-5 · Cited by 37 · see citing works
Depoortère, R., Perrault, G., & Sanger, D. J. (1997) · Behavioural Pharmacology · doi:10.1097/00008877-199708000-00009 · Cited by 37 · see citing works
Opiate-dopamine interactions in the neural substrates of acoustics startle gating in the rat
Swerdlow, N. R., Caine, S. B., & Geyer, M. A. (1991) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(91)90072-9 · Cited by 36 · see citing works
Self-citationEffects of sustained cocaine exposure on sensorimotor gating of startle in rats
Martinez, Z. A., Ellison, G. D., Geyer, M. A., et al. (1999) · Psychopharmacology · doi:10.1007/s002130050887 · Cited by 36 · see citing works
Self-citationDruhan, J. P., Geyer, M. A., & Valentino, R. J. (1998) · Psychopharmacology · doi:10.1007/s002130050513 · Cited by 36 · see citing works
Self-citationGreene, J. R. T., Kerkhoff, J. E., Guiver, L., & Totterdell, S. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00560-1 · Cited by 35 · see citing works
Pietraszek, M., & Ossowska, K. (1998) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005194 · Cited by 34 · see citing works
Behavioral effects of chronic phencyclidine in monkeys
Linn, G. S., O’Keeffe, R. T., Schroeder, C. E., et al. (1999) · Neuroreport · doi:10.1097/00001756-199909090-00017 · Cited by 34 · see citing works
Effects of LU-111995 in Three Models of Disrupted Prepulse Inhibition in Rats
Geyer, M. A., Swerdlow, N. R., Masten, V. L., Teschendorf, H.-J., Traut, M., & Gross, G. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34955-9 · Cited by 34 · see citing works
Self-citationFeifel, D. (1999) · Behavioral Neuroscience · doi:10.1037//0735-7044.113.5.1020 · Cited by 33 · see citing works
ACEA 1021, a glycine site antagonist with minor psychotomimetic and amnestic effects in rats
Kretschmer, B. D., Kratzer, U., Breithecker, K., et al. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01047-9 · Cited by 32 · see citing works
The effects of subchronic haloperidol on intact and dizocilpine-disrupted sensorimotor gating
Feifel, D., & Priebe, K. (1999) · Psychopharmacology · doi:10.1007/s002130051103 · Cited by 32 · see citing works
Regulation of sensorimotor gating by interactions of dopamine and adenosine in the rat.
Koch, M., & Hauber, W. (1998) · PubMed · Cited by 31 · see citing works
Johansson, C., Deveney, A. M., Reif, D. W., et al. (1999) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1999.tb01487.x · Cited by 30 · see citing works
Wiley, J. L. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90259-3 · Cited by 30 · see citing works
Behavioral Effects Of 8-OH-DPAT in Chronically Stressed Male and Female Rats
Sipos, M. L., Bauman, R. A., Widholm, J. J., & Kant, G. J. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00178-7 · Cited by 28 · see citing works
Geyer, M. A. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00123-2 · Cited by 28 · see citing works
Self-citationHall, F. S., Huang, S., & Fong, G. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48325.x · Cited by 28 · see citing works
Circadian Time Does Not Modify the Prepulse Inhibition Response or Its Attenuation by Apomorphine
Weiss, I. C., Feldon, J., & Domeney, A. M. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00100-8 · Cited by 26 · see citing works
Sipes, T. E., & Geyer, M. A. (1996) · Psychopharmacology · doi:10.1007/bf02247333 · Cited by 26 · see citing works
Self-citationFuruya, Y., Kagaya, T., Ogura, H., et al. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00839-5 · Cited by 26 · see citing works
Taylor, M. K., Ison, J. R., & Schwarzkopf, S. B. (1995) · Psychopharmacology · doi:10.1007/bf02246183 · Cited by 25 · see citing works
Rasmussen, K., Gates, M. R., Burger, J. E., et al. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)13346-8 · Cited by 25 · see citing works
NPC 16377, a potent and selective sigma-ligand. II. Behavioral and neuroprotective profile.
Clissold, D. B., Pontecorvo, M. J., Jones, B., et al. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38166-8 · Cited by 25 · see citing works
Zhu, J., & Stadlin, A. (2000) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(99)00076-8 · Cited by 23 · see citing works
Effects of modulation of nitric oxide on acoustic startle responding and prepulse inhibition in rats
Wiley, J. L., Golden, K. M., & Bowen, S. E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)83038-5 · Cited by 23 · see citing works
Vorhees, C. V., Reed, T. M., Schilling, M. S., Acuff‐Smith, K. D., Fisher, J. E., & Moran, M. S. (1996) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(95)02051-9 · Cited by 22 · see citing works
High doses of aspartame have no effects on sensorimotor function or learning and memory in rats
Tilson, H. A., Hong, J., & Sobotka, T. J. (1991) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(91)90024-q · Cited by 22 · see citing works
A hyperglycinergic rat model for the pathogenesis of schizophrenia: preliminary findings
Waziri, R., & Baruah, S. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00169-8 · Cited by 22 · see citing works
Amphetamine sensitivity in open-field activity vs. the prepulse inhibition paradigm
Ott, D. A., & Mandel, R. J. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(94)00276-7 · Cited by 21 · see citing works
Cysteamine Blocks Amphetamine-Induced Deficits in Sensorimotor Gating
Feifel, D. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00020-8 · Cited by 20 · see citing works
Competitive NMDA and Strychnine-Insensitive Glycine-Site Antagonists Disrupt Prepulse Inhibition
Furuya, Y., & Ogura, H. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00452-2 · Cited by 20 · see citing works
Multisensory deficits in rats produced by acute exposure to cold swim stress.
Leitner, D. S. (1989) · Behavioral Neuroscience · doi:10.1037//0735-7044.103.1.151 · Cited by 19 · see citing works
Effects of acute systemic 3-nitropropionic acid administration on rat activity and acoustic startle
Seaman, R. L. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00790-4 · Cited by 18 · see citing works
(−)Alprenolol potentiates the disrupting effects of dizocilpine on sensorimotor function in the rat
Zhang, J., Engel, J. A., Jackson, D. M., et al. (1997) · Psychopharmacology · doi:10.1007/s002130050346 · Cited by 18 · see citing works
Dose and time response analysis of apomorphine's effect on prepulse inhibition of acoustic startle
Young, K. A., Randall, P. K., & Wilcox, R. E. (1991) · Behavioural Brain Research · doi:10.1016/s0166-4328(05)80038-5 · Cited by 18 · see citing works
NMDA receptor antagonists acting at the glycine B site in rat models for antipsychotic-like activity
Karcz‐Kubicha, M., Wedzony, K., Zajaczkowski, W., et al. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050233 · Cited by 18 · see citing works
The effect of ketamine on pre-pulse inhibition and attention
Karper, L., Grillon, C., Abi‐Saab, D., et al. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(95)95554-m · Cited by 17 · see citing works
Furuya, Y., Kagaya, T., Nishizawa, Y., & Ogura, H. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01245-6 · Cited by 15 · see citing works
Mintz, M., Yovel, G., Gigi, A., & Myslobodsky, M. S. (1998) · Brain Research Bulletin · doi:10.1016/s0361-9230(97)00373-0 · Cited by 14 · see citing works
Hijzen, T. H., Broersen, L. M., & Slangen, J. L. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90254-j · Cited by 12 · see citing works
Subchronically applied phencyclidine fails to disrupt prepulse inhibition in rats
Ehrhardt, J., Sabel, B. A., & Schröeder, U. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00058-9 · Cited by 11 · see citing works
Effects of pyrethroids on the acoustic startle reflex in the rat
Hijzen, T. H., Beun, R. D., & Slangen, J. L. (1988) · Toxicology · doi:10.1016/0300-483x(88)90008-x · Cited by 10 · see citing works
Wadenberg, M.-L. G., Sills, T. L., Fletcher, P., et al. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00267-x · Cited by 9 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762 · see citing works
Cryan, J. F., Mombereau, C., & Vassout, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.009 · Cited by 1,674 · see citing works
Fone, K. C. F., & Porkess, M. V. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.03.003 · Cited by 864 · see citing works
Realistic expectations of prepulse inhibition in translational models for schizophrenia research
Swerdlow, N. R., Weber, M., Qu, Y., Light, G. A., & Braff, D. L. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1072-4 · Cited by 529 · see citing works
Self-citationCampos, A. C., Moreira, F. A., Gomes, F. V., Del Bel, E. A., & Guimarães, F. S. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0389 · Cited by 475 · see citing works
Behavioral phenotyping strategies for mutant mice
Crawley, J. N. (2008) · Neuron · doi:10.1016/j.neuron.2008.03.001 · Cited by 439 · see citing works
Convergence of biological and psychological perspectives on cognitive coordination in schizophrenia
Phillips, W. A., & Silverstein, S. M. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03000025 · Cited by 445 · see citing works
Belmonte, M. K., Cook, E. H., Anderson, G. M., Rubenstein, J. L. R., Greenough, W. T., Beckel-Mitchener, A., Courchesne, E., Boulanger, L. M., Powell, S. B., Levitt, P. R., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001499 · Cited by 442 · see citing works
Sensory Processing Dysfunction in the Personal Experience and Neuronal Machinery of Schizophrenia
Javitt, D. C., & Freedman, R. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13121691 · Cited by 403 · see citing works
Swerdlow, N. R., Light, G. A., Cadenhead, K. S., Sprock, J., Hsieh, M. H., & Braff, D. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.12.1325 · Cited by 339 · see citing works
Self-citationMolecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment
Konradi, C., & Heckers, S. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00328-5 · Cited by 336 · see citing works
Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models
Markou, A., Chiamulera, C., Geyer, M. A., Tricklebank, M., & Steckler, T. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.173 · Cited by 328 · see citing works
Self-citationModeling madness in mice: one piece at a time
Arguello, P. A., & Gogos, J. A. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.023 · Cited by 309 · see citing works
Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299 · see citing works
Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice.
Frankland, P. W., Wang, Y., Rosner, B., Shimizu, T., Balleine, B. W., Dykens, E. M., Ornitz, E. M., & Silva, A. J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001432 · Cited by 275 · see citing works
Murray, J. D., Anticevic, A., Gancsos, M., Ichinose, M., Corlett, P. R., Krystal, J. H., & Wang, X.-J. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhs370 · Cited by 255 · see citing works
The 5-HT7 receptor and disorders of the nervous system: an overview
Hedlund, P. B. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1626-0 · Cited by 239 · see citing works
Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models
Malone, D. T., Hill, M. N., & Rubino, T. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00721.x · Cited by 237 · see citing works
Cryan, J. F., Bruijnzeel, A. W., Skjei, K. L., & Markou, A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1445-7 · Cited by 223 · see citing works
Prepulse inhibition and genetic mouse models of schizophrenia
Powell, S. B., Zhou, X., & Geyer, M. A. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.04.021 · Cited by 218 · see citing works
Self-citationCui, C., Booker, T. K., Allen, R. S., Grady, S. R., Whiteaker, P., Marks, M. J., Salminen, O., Tritto, T., Butt, C. M., Allen, W. R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11045.2003 · Cited by 213 · see citing works
Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission
Karayannis, T., Au, E., Patel, J. C., Kruglikov, I., Markx, S., Delorme, R., Héron, D., Salomon, D., Glessner, J., Restituito, S., et al. (2014) · Nature · doi:10.1038/nature13248 · Cited by 183 · see citing works
Abdul-Monim, Z., Neill, J. C., & Reynolds, G. P. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107067097 · Cited by 206 · see citing works
Vanderschuren, L. J. M. J., & Trezza, V. (2013) · Current Topics in Behavioral Neurosciences · doi:10.1007/978-3-662-45758-0_268 · Cited by 200 · see citing works
Leopoldo, M., Lacivita, E., Berardi, F., Perrone, R., & Hedlund, P. B. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.013 · Cited by 198 · see citing works
Impaired sensorimotor gating in unmedicated adults with obsessive-compulsive disorder
Ahmari, S. E., Risbrough, V. B., Geyer, M. A., & Simpson, H. B. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.308 · Cited by 189 · see citing works
Self-citationChen, Y.-J. J., Johnson, M. A., Lieberman, M. D., Goodchild, R. E., Schobel, S., Lewandowski, N., Rosoklija, G., Liu, R.-C., Gingrich, J. A., Small, S., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1815-08.2008 · Cited by 188 · see citing works
López-Gil, X., Babot, Z., Amargós-Bosch, M., Suñol, C., Artigas, F., & Adell, A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301356 · Cited by 183 · see citing works
Glutamatergic Synaptic Dysregulation in Schizophrenia: Therapeutic Implications
Coyle, J. T., Basu, A., Benneyworth, M., Balu, D., & Konopaske, G. (2012) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-25758-2_10 · Cited by 180 · see citing works
Zhang, T. Y., Chrétien, P., Meaney, M. J., & Gratton, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3293-04.2005 · Cited by 174 · see citing works
Current animal models of obsessive compulsive disorder: a critical review
Joel, D. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.11.006 · Cited by 168 · see citing works
The family of sensorimotor gating disorders: Comorbidities or diagnostic overlaps?
Geyer, M. A. (2006) · Neurotoxicity Research · doi:10.1007/bf03033358 · Cited by 159 · see citing works
Self-citationTranslating cognition from animals to humans
Keeler, J. F., & Robbins, T. W. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.12.028 · Cited by 137 · see citing works
Guo, X., Hamilton, P. J., Reish, N. J., Sweatt, J. D., Miller, C. A., & Rumbaugh, G. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.223 · Cited by 120 · see citing works
Bayesian estimation of synaptic physiology from the spectral responses of neural masses
Moran, R. J., Stephan, K. E., Kiebel, S. J., Rombach, N., O'Connor, W. T., Murphy, K. J., Reilly, R. B., & Friston, K. J. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.01.025 · Cited by 126 · see citing works
Riba, J., Anderer, P., Morte, A., Urbano, G., Jané, F., Saletu, B., & Barbanoj, M. J. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01609.x · Cited by 125 · see citing works
Perception Measurement in Clinical Trials of Schizophrenia: Promising Paradigms From CNTRICS
Green, M. F., Butler, P. D., Chen, Y., Geyer, M. A., Silverstein, S., Wynn, J. K., Yoon, J. H., & Zemon, V. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn156 · Cited by 113 · see citing works
Self-citationGenetic contributions to behavioural diversity at the gene-environment interface
Bendesky, A., & Bargmann, C. I. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3065 · Cited by 103 · see citing works
A Review of Oxytocin’s Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia
Feifel, D., Shilling, P. D., & MacDonald, K. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.025 · Cited by 110 · see citing works
Dopamine D1 Rather than D2 Receptor Agonists Disrupt Prepulse Inhibition of Startle in Mice
Ralph-Williams, R. J., Lehmann-Masten, V., & Geyer, M. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300017 · Cited by 105 · see citing works
Self-citationBarr, A. M., Lehmann-Masten, V., Paulus, M., Gainetdinov, R. R., Caron, M. G., & Geyer, M. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300343 · Cited by 103 · see citing works
Self-citationSleep deprivation disrupts prepulse inhibition and induces psychosis-like symptoms in healthy humans
Petrovsky, N., Ettinger, U., Hill, A., Frenzel, L., Meyhofer, I., Wagner, M., Backhaus, J., & Kumari, V. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0904-14.2014 · Cited by 102 · see citing works
Shanahan, N. A., Holick Pierz, K. A., Masten, V. L., Waeber, C., Ansorge, M., Gingrich, J. A., Geyer, M. A., Hen, R., & Dulawa, S. C. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.09.026 · Cited by 102 · see citing works
Self-citationEpigenetic changes at gene promoters in response to immune activation in utero
Tang, B., Jia, H., Kast, R. J., & Thomas, E. A. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.01.086 · Cited by 91 · see citing works
Braff, D. L., Light, G. A., & Swerdlow, N. R. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.015 · Cited by 90 · see citing works
Self-citationHawk, L. W., Yartz, A. R., Pelham, W. E., & Lock, T. M. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1235-7 · Cited by 89 · see citing works
Gomes, F. V., Issy, A. C., Ferreira, F. R., Viveros, M.-P., Del Bel, E. A., & Guimarães, F. S. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu041 · Cited by 89 · see citing works
Glycine transport inhibitors in the treatment of schizophrenia
Javitt, D. C. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25758-2_12 · Cited by 83 · see citing works
Powell, S. B., Geyer, M. A., Preece, M. A., Pitcher, L. K., Reynolds, G. P., & Swerdlow, N. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00122-2 · Cited by 82 · see citing works
Self-citationNegative and Nonemotional Interference with Visual Working Memory in Schizophrenia
Anticevic, A., Repovs, G., Corlett, P. R., & Barch, D. M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.010 · Cited by 75 · see citing works
Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine
Pedrazzi, J. F. C., Issy, A. C., Gomes, F. V., Guimarães, F. S., & Del-Bel, E. A. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3945-7 · Cited by 76 · see citing works
Kapfhamer, D., Berger, K. H., Hopf, F. W., Seif, T., Kharazia, V., Bonci, A., & Heberlein, U. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1292-10.2010 · Cited by 71 · see citing works
The potential role of lamotrigine in schizophrenia
Large, C. H., Webster, E. L., & Goff, D. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0020-9 · Cited by 69 · see citing works
Behavioral and molecular evidence for psychotropic effects in l-theanine
Wakabayashi, C., Numakawa, T., Ninomiya, M., Chiba, S., & Kunugi, H. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2440-z · Cited by 65 · see citing works
Rosch, R. E., Auksztulewicz, R., Leung, P. D., Friston, K. J., & Baldeweg, T. (2019) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2018.07.003 · Cited by 56 · see citing works
Gulchina, Y., Xu, S., Snyder, M. A., Elefant, F., & Gao, W. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14101 · Cited by 56 · see citing works
Powell, S. B., Young, J. W., Ong, J. C., Caron, M. G., & Geyer, M. A. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830dc110 · Cited by 57 · see citing works
Self-citationDugué, G. P., Lörincz, M. L., Lottem, E., Audero, E., Matias, S., Correia, P. A., Léna, C., & Mainen, Z. F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105941 · Cited by 54 · see citing works
Predictably irrational: assaying cognitive inflexibility in mouse models of schizophrenia
Brigman, J. L. (2010) · Frontiers in Neuroscience · doi:10.3389/neuro.01.013.2010 · Cited by 52 · see citing works
Maternal overnutrition induces long-term cognitive deficits across several generations
Sarker, G., & Peleg-Raibstein, D. (2018) · Nutrients · doi:10.3390/nu11010007 · Cited by 52 · see citing works
Allen, J. A., Yadav, P. N., Setola, V, Farrell, M., & Roth, B. L. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.35 · Cited by 37 · see citing works
Carreno, F. R., Collins, G. T., Frazer, A., & Lodge, D. J. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx003 · Cited by 31 · see citing works
Kozikowski, A. P., Cho, S. J., Jensen, N. H., Allen, J. A., Svennebring, A. M., & Roth, B. L. (2010) · ChemMedChem · doi:10.1002/cmdc.201000186 · Cited by 28 · see citing works
Mouse model of neurological complications resulting from encephalitic alphavirus infection
Ronca, S. E., Smith, J., Koma, T., Miller, M. M., Yun, N., Dineley, K. T., & Paessler, S. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00188 · Cited by 22 · see citing works
Effect of <scp>L</scp>‐theanine on sensorimotor gating in healthy human subjects
Ota, M., Wakabayashi, C., Matsuo, J., Kinoshita, Y., Hori, H., Hattori, K., Sasayama, D., Teraishi, T., Obu, S., Ozawa, H., et al. (2014) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12134 · Cited by 16 · see citing works
Feifel, D., Shilling, P. D., Hillman, J., Maisel, M., Winfield, J., & Melendez, G. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.10.023 · Cited by 13 · see citing works
- Authors
- Geyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R.
- Affiliations
- University of California San Diego (US)
- Venue
- Psychopharmacology
- Published
- 2001-06-22
- Volume
- 156
- Issue
- 2-3
- Pages
- 117-154
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2005756201
- Cited by
- 1,484
- References
- 194
- Citations by year
- 2026: 17 · 2025: 13 · 2024: 23 · 2023: 37 · 2022: 34 · 2021: 41 · 2020: 27 · 2019: 38 · 2018: 36 · 2017: 47 · 2016: 62 · 2015: 64 · 2014: 48 · 2013: 69 · 2012: 74
- FWCI
- 42.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH 52885, MH42228, MH61326, R01MH061326, R01MH052885)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- prepulse inhibition, animal models of schizophrenia, dopamine D2 receptor agonist, amphetamine, apomorphine, NMDA receptor antagonists, phencyclidine, clozapine, atypical antipsychotics, isolation rearing, systemic drug administration
- MeSH terms
- Animals, Humans, Schizophrenia, Schizophrenic Psychology, Reflex, Startle
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review